Volume 33 Number 22 December 4-11, 2014
Cancer
20 years of lesson learning: how does the ret genetic screening test impact the clinical management of medullary thyroid cancer?
Romei C, et al. Clin Endocrinol (Oxf) 2014 Dec
Romei C, et al. Clin Endocrinol (Oxf) 2014 Dec
Age-related clonal hematopoiesis associated with adverse outcomes.
Jaiswal S, et al. N Engl J Med. 2014 Nov 26.
Jaiswal S, et al. N Engl J Med. 2014 Nov 26.
BRAF mutation in papillary thyroid cancer: A cost-utility analysis of preoperative testing
Lee WS, et al. Surgery 2014 Dec;156(6):1569-78
Lee WS, et al. Surgery 2014 Dec;156(6):1569-78
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Genovese G, et al. N Engl J Med. 2014 Nov 26.
Genovese G, et al. N Engl J Med. 2014 Nov 26.
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing.
Manchanda R et al. J Natl Cancer Inst. 2014 Nov 30;107(1). pii: dju380. doi: 10.1093/jnci/dju380. Print 2015 Jan.
Manchanda R et al. J Natl Cancer Inst. 2014 Nov 30;107(1). pii: dju380. doi: 10.1093/jnci/dju380. Print 2015 Jan.
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: A randomized controlled trial.
Manchanda R, et al. J Natl Cancer Inst. 2014 Nov 30;107(1). pii: dju379. doi: 10.1093/jnci/dju379. Print 2015 Jan.
Manchanda R, et al. J Natl Cancer Inst. 2014 Nov 30;107(1). pii: dju379. doi: 10.1093/jnci/dju379. Print 2015 Jan.
Current way of detecting gene mutations misses people at high risk of cancer, Medical Xpress, Dec 1
'Screen more' for cancer risk genes, by James Gallagher, BBC, Nov 30
Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening
Cubiella J, et al. United European Gastroenterol J 2014 Dec;2(6):522-9
Cubiella J, et al. United European Gastroenterol J 2014 Dec;2(6):522-9
Genetic features of Lynch syndrome in the Israeli population
Goldberg Y, et al. Clin Genet 2014 Nov
Goldberg Y, et al. Clin Genet 2014 Nov
Identifying hereditary cancer: Genetic counseling and cancer risk assessment
Marie Lewis K Curr Probl Cancer 2014 Oct
Marie Lewis K Curr Probl Cancer 2014 Oct
Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma
Mancini I, et al. Clin Chim Acta 2015 Jan;439C:128-36
Mancini I, et al. Clin Chim Acta 2015 Jan;439C:128-36
Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.
Lei Li et al. Nat Commun. 2014 Nov 28;5:5469.
Lei Li et al. Nat Commun. 2014 Nov 28;5:5469.
Integration of genomic data enables selective discovery of breast cancer drivers.
Sanchez-Garcia F, et al. Cell. 2014 Nov 25. pii: S0092-8674(14)01375-0.
Sanchez-Garcia F, et al. Cell. 2014 Nov 25. pii: S0092-8674(14)01375-0.
Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer
Vilar E, et al. Cancer Genet 2014 Oct
Vilar E, et al. Cancer Genet 2014 Oct
Smarter screening for cancer: Possibilities and challenges of personalization.
Sameer D. Saini, JAMA December 3, 2014
Sameer D. Saini, JAMA December 3, 2014
Two studies identify a detectable, pre-cancerous state in the blood - Findings pave way for new lines of cancer research focused on detection and prevention, Broad Institute, Boston, Mass. Nov 25
Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial
Kapp JR, et al. J Clin Pathol 2014 Nov
Kapp JR, et al. J Clin Pathol 2014 Nov
Optimizing HER2 therapy in early and advanced breast cancers, by Alice Goodman, ASCO Post, Dec 1
No hay comentarios:
Publicar un comentario